{"SPADE_UN_19364": {"Sequence Information": {"Peptide Name": "Modified Clavanin A", "Sequence": "FLPIIVFQFLGKIIHHVGNFVHGFSHVF", "Sequence Length": 28, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antiviral", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P80710", "uniprotUrl": "http://www.uniprot.org/uniprot/P80710", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: An endodontic perspective.", "Pubmed ID": "28712894", "Reference": "Peptides. 2017;95:16-24", "Author": "Lima SMF, Freire MS, Gomes ALO, Cantuária APC, Dutra FRP, Magalhães BS, Sousa MGC, Migliolo L, Almeida JA, Franco OL, Rezende TMB", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28712894"}, {"Title": "Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus", "Pubmed ID": "27161201", "Reference": "Biopolymers. 2017;108:", "Author": "Vilas Boas LCP, de Lima LMP, Migliolo L, Mendes GD, de Jesus MG, Franco OL, Silva PA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27161201"}, {"Title": "An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.", "Pubmed ID": "27804992", "Reference": "Sci Rep. 2016;6:35465", "Author": "Silva ON, de la Fuente-Núnez C, Haney EF, Fensterseifer IC,  Ribeiro SM, Porto WF, Brown P, Faria-Junior C, Rezende TMB, Moreno SE, Lu TK, Hancock RE, Franco OL", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27804992"}], "Mass": 3250.84, "PI": 8.78, "Net Charge": 5, "Hydrophobicity": 1.14, "Frequent Amino Acids": "FHI", "Absent Amino Acids": "ACDEMORTUWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 16, "Polar Residues": 12, "Positive Residues": 5, "Negative Residues": 0, "SPADE ID": "SPADE_UN_19364", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_19364", "Similarity": 1.0, "Sequence": "FLPIIVFQFLGKIIHHVGNFVHGFSHVF"}, {"SPADE_ID": "SPADE_N_02234", "Similarity": 1.0, "Sequence": "VFQFLGKIIHHVGNFVHGFSHVF"}, {"SPADE_ID": "SPADE_N_02235", "Similarity": 0.9565217391304348, "Sequence": "VFQFLGRIIHHVGNFVHGFSHVF"}], "Hemolytic Activity": "Vero cells:50% Cell death=200 µg/ml,Mouse erythrocytes:<10% Hemolysis=200 µM,Mouse fibroblasts L929:LC50=>600 µM,Human embryonic kidney HEK293 cells:LC50=>600 µM", "Target Organism": "Candida albicans ATCC 10231(20-30% Inhibition=128µg/ml),Enterococcus faecalis ATCC 29212(0-10% Inhibition=128µg/ml),Murine macrophage cells RAW 264.7(LC50=37µM),Aichi virus(no activity data),Bacillus subtilis ATCC 6633(MIC=1.5µM),Enterococcus faecalis ATCC 12953(MIC=1.5µM),Staphylococcus aureus ATCC 29213(MIC=24.0µM),Staphylococcus aureus ATCC 33591(MIC=6.0µM),Streptococcus pyogenes ATCC 19615(MIC=6.0µM),Escherichia coli ATCC 8739(MIC=12.0µM),Escherichia coli KPC 001812446(MIC=6.0µM),Escherichia coli KPC 002101123(MIC=6.0µM),Klebsiella pneumoniae ATCC 13885(MIC=3.0µM),Klebsiella pneumoniae KPC 001825971(MIC=3.0µM),Proteus mirabilis ATCC 25933(MIC=6.0µM),Pseudomonas aeruginosa ATCC 15442(MIC=3.0µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=3.0µM),Murine macrophage cells RAW 264.7(LC50=>600µM)"}}}